Stem Cell Therapy for ARDS

Acute Respiratory Distress Syndrome (ARDS) is a severe lung condition that results in damage to lung tissue due to various underlying causes. While current treatments for ARDS focus primarily on managing symptoms, they do not address the underlying cause of the disease. Stem Cell Therapy presents a promising alternative, as it targets the root cause of lung damage, offering potential for more effective recovery.

ARDS is a life-threatening condition characterized by severe injury to the lungs, leading to fluid accumulation in the alveoli (air sacs). This fluid buildup prevents oxygen from properly entering the bloodstream, making breathing increasingly difficult. ARDS often develops in hospitalized patients, particularly those who are critically ill or have experienced trauma or infection.

Acute Respiratory Distress Syndrome (ARDS) can arise from various underlying causes, including:

Mechanical Factors: Fluid leakage from the tiny blood vessels in the lungs, often caused by changes in pressure or tension within the lungs.

Severe Illnesses and Injuries: Serious health conditions or trauma can trigger ARDS.

Sepsis: A severe and widespread bloodstream infection that can lead to ARDS.

Inhalation of Harmful Substances: Exposure to high concentrations of chemical fumes, smoke, or other toxic substances can damage the lungs and cause ARDS.

Pneumonia: A lung infection that affects multiple lobes, potentially leading to ARDS.

Major Traumatic Injuries: Injuries to the head, chest, or lungs can trigger ARDS. In cases of brain injury, damage to the part of the brain that controls breathing may also contribute.

COVID-19: Severe cases of COVID-19 can lead to the development of ARDS.

Other Factors: Burns, blood transfusions, and pancreatitis (inflammation of the pancreas) are also potential triggers for ARDS.

Acute Respiratory Distress Syndrome (ARDS) most commonly occurs in patients who are critically ill or hospitalized for serious medical conditions. Those at a higher risk of developing ARDS include:

Patients with Sepsis: A severe bloodstream infection that can lead to widespread inflammation, increasing the likelihood of ARDS.

Individuals with a History of Substance Abuse: People with a history of chronic drug abuse or alcoholism are more susceptible to developing ARDS, and they may also face a higher risk of mortality due to the condition.

These factors significantly increase the likelihood of ARDS, making early detection and intervention crucial.

The symptoms of Acute Respiratory Distress Syndrome (ARDS) can vary depending on several factors, including:

The underlying cause of the condition

The severity of the disease

Any pre-existing health conditions

However, the most common symptoms of ARDS include:

Shortness of breath (SOB)

Rapid breathing

Low blood pressure

Severe confusion and extreme fatigue

The management of Acute Respiratory Distress Syndrome (ARDS) typically involves a combination of supportive care and targeted interventions to improve oxygenation and address underlying causes. Key treatment strategies include:

Mechanical Ventilation: Utilizing a ventilator to support breathing and maintain adequate oxygen levels in the lungs.

Supplemental Oxygen: Providing additional oxygen through a mask or nasal cannula to ensure sufficient oxygen delivery to the blood.

Fluid Management: Carefully monitoring and regulating intravenous (IV) fluid levels to prevent fluid overload, which can worsen lung function.

Medications: Administering drugs to:

Treat and prevent infections

Alleviate pain and discomfort

Prevent blood clots

Reduce gastric reflux

Sedate the patient to improve comfort and facilitate mechanical ventilation.

Stem Cells are the natural repair process of your body parts, and they are present in our fat cells, bone marrow cells and in this case, we use Mesenchymal Stem Cells from donor cord blood. If you place the SCs over the area of damage, then these cells can lead to the activation of new and healthy cells. This healing process is what our body needs. Stem Cell Therapy helps boost body repair mechanisms and introduces the new stem cells.

Research suggests that mesenchymal stem cell (MSC) therapy offers a promising therapeutic alternative for the treatment of Acute Respiratory Distress Syndrome (ARDS). Unlike conventional treatments that focus on managing symptoms and preventing complications, MSC therapy targets the root cause by promoting the repair and regeneration of lung tissue.

In ARDS, MSCs aid in replacing damaged lung tissue with healthy, native cells, helping to restore lung function. This regenerative approach positions stem cell therapy as a potential breakthrough in treating ARDS, offering a more effective solution compared to traditional therapies.

Acute Respiratory Distress Syndrome (ARDS) is a severe lung condition that involves an excessive immune response, leading to widespread inflammation in the lungs. The immune response in ARDS can become dysregulated, resulting in damage to lung tissue and impairment of gas exchange. The key immune-related issues in ARDS include:

1. Excessive Inflammation

o ARDS often arises from an exaggerated inflammatory response triggered by infections, trauma, or other conditions. This hyperinflammation causes the release of cytokines, chemokines, and other immune mediators that recruit immune cells to the lungs. While this response aims to combat the initial insult, excessive inflammation can damage the alveoli, the tiny air sacs responsible for oxygen exchange.

2. Cytokine Storm

o A key feature of ARDS is the development of a "cytokine storm," where an overproduction of pro-inflammatory cytokines (such as IL-6, IL-8, TNF-α) leads to uncontrolled immune activity. This storm causes capillary leakage, pulmonary edema (fluid buildup in the lungs), and further lung injury.

3. Endothelial and Epithelial Damage

o The immune response in ARDS can damage the endothelial cells lining the blood vessels and the epithelial cells lining the alveoli. This damage disrupts the integrity of the lung barrier, allowing fluid and immune cells to flood into the alveoli, leading to impaired oxygenation and respiratory failure.

4. Neutrophil Activation

o Neutrophils, a type of white blood cell, play a critical role in ARDS. During the immune response, they are activated and migrate to the lungs, releasing enzymes and reactive oxygen species. While neutrophils help clear pathogens, their overactivation can lead to tissue damage, worsening lung injury.

5. Immunothrombosis

o In ARDS, there is often an interaction between the immune response and the coagulation system, leading to immunothrombosis —the formation of blood clots in the microvasculature of the lungs. This further disrupts blood flow and oxygen exchange, contributing to the severity of the condition.

6. Immunosuppression

Paradoxically, as ARDS progresses, patients may also experience immune suppression. After the initial inflammatory phase, the immune system may become dysregulated, leading to an impaired ability to clear infections. This can result in secondary infections, complicating the treatment of ARDS.

Generally, Stem Cell Therapy has a satisfactory safety profile, good prognosis, and effectiveness.

However, no medical procedure is 100% safe; so, the most frequent or common risk factors of SCT can be:

Painful injection area /site

Allergic reactions

Lethargy and fatigue

Bleeding from the site of injection

Fever

Stem Cell Therapy (SCT) at The Renue Medical Centre is a holistic approach to treating Acute Respiratory Distress Syndrome.

Your Renue Journey does not end after your last day of SCT. We follow up with you to assert your progress since the treatment of Acute Respiratory Distress Syndrome with Stem Cells consists of four phases:

Pre-treatment: Clinical evaluation, lab test results, and other diagnostic procedures. You will take our Renue Epigenetic Test powered by TruDiagnostics that will assert your biological age and other important health markers. Your TruDiagnostics test is part of The Renue Difference. It provides your doctor with critical information about your health and your true age (biological vs chronological).

After the epigenetic test and we have received all your medical records, your Patient Advisor will assist you in planning your travel to Puerto Vallarta.

Treatment day: The treatment starts with taking a specific amount of blood through apheresis. After taking the Stem Cells, the rest of the blood is returned to the donor.

30, 60 & 90 days post-treatment follow-up: ARDS symptoms clinical evaluation, flare-up frequency, and lab test results.

Six months post-treatment: ARDS symptoms clinical evaluation, flare-up frequency, lab test results, X-ray report, and review of the diagnostic criteria.

SCT to live a better life: Benefits and outcomes

The effectiveness of Stem Cell Treatment can improve all your symptoms, causing a considerable impact on your quality of life and daily activities.

As part of The Renue Difference, you will receive three Hyperbaric Chamber sessions that greatly improve SCT efficacy and stimulate the body cells to combat Acute Respiratory Distress Syndrome. These sessions comprise three days: one day before treatment, after treatment, and on the day of treatment.

According to results, clinical outcomes, and pre-and post-treatment observations, SCT has been shown to help

reduce Acute Respiratory Distress Syndrome progression

speed up tissue repair

regrow and repair tissues after six months

After the SCT procedure, an MRI test depicts the further need for the treatment at a specific body site.

Talk to our Patient Advisor to learn more about SCT at The Renue Medical Centre.

Expected results and prognosis:

The patient will have new lung tissues, increased quality of life, and improved illness conditions with Stem Cell Therapy.

Fever, lethargy, and pain are managed through the appropriate drugs along with the treatment. Bleeding and swelling of the injured site is manageable via proper technique. Allergic reactions are preventable through pre-injection history and care.